Garrett Bullock
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Garrett Bullock has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Martin L. Katz
Department of Ophthalmology, School of Medicine, University of Missouri, Columbia, MO 65212, USA
16 shared publications - Juyuan Guo
Canine Genetics Laboratory, Department of Veterinary Pathobiology, College of Veterinary Medicine, University of Missouri, Columbia, MO 65211, USA
8 shared publications - Gary S. Johnson
Canine Genetics Laboratory, Department of Veterinary Pathobiology, College of Veterinary Medicine, University of Missouri, Columbia, MO 65211, USA
7 shared publications - Tendai Mhlanga-Mutangadura
University of Missouri, USA
6 shared publications - Dennis P. O'Brien
Department of Veterinary Medicine and Surgery, College of Veterinary Medicine, University of Missouri, Columbia, MO 65211, USA
3 shared publications - Lucie Chevallier
U955—IMRB, Team 10—Biology of the Neuromuscular System, Institut National de la Santé et de la Recherche Médicale, Ecole Nationale Vétérinaire d’Alfort, 94704 Maisons-Alfort, France
3 shared publications
Latest Publications
- Open Access
- 28 July 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (8) , 1099
Congenital Myasthenic Syndrome in Doberman Pinscher Dogs Is Associated with a Homozygous Missense Variant in AGRN
Hereditary neuromuscular disorders in dogs can be difficult to classify since variants in different genes can result in similar clinical signs or variable phenotypes can be associated with the same DNA sequence variant. A disorder known for many years as Dancing Doberman Disease, suspected to be neuropathy or neuromyopathy, is characterized by repeated lifting and shifting of the pelvic limbs while standing and frequent sitting. More recently, Doberman Pinschers have been identified with a different and more severe phenotype characterized by a crouched stance and bunny hopping gait in the pelvic limbs that is termed duck walking. Dogs with both phenotypes show pelvic limb weakness, muscle atrophy, and fatigue, and clinical signs can progress to involve the thoracic limbs. These distinct phenotypes were evaluated clinically, histologically, and by whole-genome sequencing and genotyping a large cohort of affected and unaffected Doberman Pinschers. The same homozygous missense variant in AGRN (Dog 10K Boxer Tasha chr5:56,346,611,G>A; p.R1710H, XP 038377340.1) was associated with both disorders. AGRN encodes Agrin, an essential synaptic protein, that mediates clustering of acetylcholine receptors on the post-synaptic membrane at the neuromuscular junction. Variants in AGRN are associated with a congenital myasthenic syndrome (CMS) in humans. This is the first report of a CMS in dogs associated with an AGRN variant and expands the spectrum of known CMS genetic risk factors in this species. This study also highlights the importance of whole-genome sequencing (WGS) to accurately classify neuromuscular diseases as forms of CMS, which is not possible based on clinical presentation alone.
- 28 July 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (8) , 1099
Open AccessCongenital Myasthenic Syndrome in Doberman Pinscher Dogs Is Associated with a Homozygous Missense Variant in AGRN
Hereditary neuromuscular disorders in dogs can be difficult to classify since variants in different genes can result in similar clinical signs or variable phenotypes can be associated with the same DNA sequence variant. A disorder known for many years as Dancing Doberman Disease, suspected to be neuropathy or neuromyopathy, is characterized by repeated lifting and shifting of the pelvic limbs while standing and frequent sitting. More recently, Doberman Pinschers have been identified with a different and more severe phenotype characterized by a crouched stance and bunny hopping gait in the pelvic limbs that is termed duck walking. Dogs with both phenotypes show pelvic limb weakness, muscle atrophy, and fatigue, and clinical signs can progress to involve the thoracic limbs. These distinct phenotypes were evaluated clinically, histologically, and by whole-genome sequencing and genotyping a large cohort of affected and unaffected Doberman Pinschers. The same homozygous missense variant in AGRN (Dog 10K Boxer Tasha chr5:56,346,611,G>A; p.R1710H, XP 038377340.1) was associated with both disorders. AGRN encodes Agrin, an essential synaptic protein, that mediates clustering of acetylcholine receptors on the post-synaptic membrane at the neuromuscular junction. Variants in AGRN are associated with a congenital myasthenic syndrome (CMS) in humans. This is the first report of a CMS in dogs associated with an AGRN variant and expands the spectrum of known CMS genetic risk factors in this species. This study also highlights the importance of whole-genome sequencing (WGS) to accurately classify neuromuscular diseases as forms of CMS, which is not possible based on clinical presentation alone.
- Open Access
- 12 November 2025
- Published by MDPI AG in Veterinary Sciences
- Vol. 12 (11) , 1078
Retinal Function Deficits in American Staffordshire Terriers with a Late-Onset Neurodegenerative Disease Associated with an ARSG Variant
American Staffordshire Terriers (ASTs) with a c.296G>A variant in ARSG develop progressive ataxia, cerebellar atrophy, and neuronal accumulation of autofluorescent storage material. Human subjects with ARSG variants exhibit hearing loss and rod–cone dystrophy without apparent other neurological involvement and arsg knockout mice exhibit progressive ataxia, lysosomal storage, and photoreceptor loss. Owners of 8 of 11 affected ASTs evaluated for the ARSG risk variant reported observing visual impairment in their dogs, suggesting that the canine disease may involve retinal dysfunction consistent with human subjects and mice with ARSG variants. To assess whether this might be the case, electroretinography was performed on four affected and three unaffected ASTs. Three affected dogs that were exhibiting signs of ataxia had attenuated electroretinogram (ERG) amplitudes indicative of rod and cone photoreceptor dysfunction, while ERG responses were not attenuated in a younger dog that had not yet shown signs of ataxia or visual impairment. Autofluorescent inclusions were observed in the retinal pigment epithelium and retinal ganglion cell layer of two affected dogs that were euthanized due to neurological disease progression. The results from these cases indicate that standardized electroretinography can be used to detect retinal dysfunction in dogs with the ARSG-related disorder and in other disorders in which dogs exhibit apparent impairment in visually mediated behavior.
- 12 November 2025
- Published by MDPI AG in Veterinary Sciences
- Vol. 12 (11) , 1078
Open AccessRetinal Function Deficits in American Staffordshire Terriers with a Late-Onset Neurodegenerative Disease Associated with an ARSG Variant
American Staffordshire Terriers (ASTs) with a c.296G>A variant in ARSG develop progressive ataxia, cerebellar atrophy, and neuronal accumulation of autofluorescent storage material. Human subjects with ARSG variants exhibit hearing loss and rod–cone dystrophy without apparent other neurological involvement and arsg knockout mice exhibit progressive ataxia, lysosomal storage, and photoreceptor loss. Owners of 8 of 11 affected ASTs evaluated for the ARSG risk variant reported observing visual impairment in their dogs, suggesting that the canine disease may involve retinal dysfunction consistent with human subjects and mice with ARSG variants. To assess whether this might be the case, electroretinography was performed on four affected and three unaffected ASTs. Three affected dogs that were exhibiting signs of ataxia had attenuated electroretinogram (ERG) amplitudes indicative of rod and cone photoreceptor dysfunction, while ERG responses were not attenuated in a younger dog that had not yet shown signs of ataxia or visual impairment. Autofluorescent inclusions were observed in the retinal pigment epithelium and retinal ganglion cell layer of two affected dogs that were euthanized due to neurological disease progression. The results from these cases indicate that standardized electroretinography can be used to detect retinal dysfunction in dogs with the ARSG-related disorder and in other disorders in which dogs exhibit apparent impairment in visually mediated behavior.
- Open Access
Canine Neuronal Ceroid Lipofuscinosis-like Disorder Associated with Sequence Variants in AP3B1 and TRAPPC9
Background/Objectives: A Petit Bleu de Gascogne (PBDG) dog presented with a progressive neurological disorder characterized by hind-limb weakness, anxiety and hallucinatory episodes, lip smacking, progressive vision loss, muscle atrophy, and ataxia. Magnetic resonance imaging revealed diffuse brain atrophy. The dog was euthanized at approximately 23 months of age due to the progression of neurological signs. A study was undertaken to identify the molecular genetic basis of the disorder in this dog. Methods: Microscopic analyses were performed to characterize the disease pathology and whole-genome sequencing was performed to identify the molecular genetic basis of the disorder. Results: The proband exhibited pronounced accumulations of autofluorescent intracellular inclusions in the brain, retina, and heart with ultrastructural appearances similar to those of lysosomal storage bodies that accumulate in the neuronal ceroid lipofuscinosis (NCLs), a group of progressive neurodegenerative disorders. Whole-genome sequence analysis of DNA from the proband identified homozygous missense variants in AP3B1 and TRAPPC9 that encode proteins involved in sorting and transport of proteins through the Golgi apparatus to lysosomes. Screening of unaffected PBDGs for these variants identified dogs that were homozygous for either variant, but no other dogs that were homozygous for both. Conclusions: These findings raise the possibility that the disease involves the combined influence of the two variants, and that the proteins encoded by these genes interact within the Golgi apparatus to mediate protein sorting and transport to lysosomes. An alteration in this interaction could underlie the NCL-like lysosomal storage disorder observed in the proband.
Open AccessCanine Neuronal Ceroid Lipofuscinosis-like Disorder Associated with Sequence Variants in AP3B1 and TRAPPC9
Background/Objectives: A Petit Bleu de Gascogne (PBDG) dog presented with a progressive neurological disorder characterized by hind-limb weakness, anxiety and hallucinatory episodes, lip smacking, progressive vision loss, muscle atrophy, and ataxia. Magnetic resonance imaging revealed diffuse brain atrophy. The dog was euthanized at approximately 23 months of age due to the progression of neurological signs. A study was undertaken to identify the molecular genetic basis of the disorder in this dog. Methods: Microscopic analyses were performed to characterize the disease pathology and whole-genome sequencing was performed to identify the molecular genetic basis of the disorder. Results: The proband exhibited pronounced accumulations of autofluorescent intracellular inclusions in the brain, retina, and heart with ultrastructural appearances similar to those of lysosomal storage bodies that accumulate in the neuronal ceroid lipofuscinosis (NCLs), a group of progressive neurodegenerative disorders. Whole-genome sequence analysis of DNA from the proband identified homozygous missense variants in AP3B1 and TRAPPC9 that encode proteins involved in sorting and transport of proteins through the Golgi apparatus to lysosomes. Screening of unaffected PBDGs for these variants identified dogs that were homozygous for either variant, but no other dogs that were homozygous for both. Conclusions: These findings raise the possibility that the disease involves the combined influence of the two variants, and that the proteins encoded by these genes interact within the Golgi apparatus to mediate protein sorting and transport to lysosomes. An alteration in this interaction could underlie the NCL-like lysosomal storage disorder observed in the proband.
- Open Access
- 27 October 2025
- Published by MDPI AG in Preprints.org
Neuronal Ceroid Lipofuscinosis-Like Disorder in a Petit Bleu de Gascogne Dog with Sequence Variants in AP3B1 and TRAPPC9
Background/Objectives: A Petit Bleu de Gascogne (PBDG) dog presented with a progressive neurological disorder characterized by hind limb weakness, anxiety and hal-lucinatory episodes, lip smacking, progressive vision loss, muscle atrophy, and ataxia. Magnetic resonance imaging revealed diffuse brain atrophy. The dog was euthanized at approximately 23 months of age due to the progression of neurological signs. A study was undertaken to identify the molecular genetic basis of the disorder in this dog. Methods: Microscopic analyses were performed to characterize the disease pathology and whole genome sequencing was performed to identify the molecular genetic basis of the disorder. Results: The proband exhibited pronounced accumulations of autofluorescent intracellu-lar inclusions in the brain, retina, and heart with ultrastructural appearances similar to those of lysosomal storage bodies that accumulate in the neuronal ceroid lipofuscinosis (NCLs), a group of progressive neurodegenerative disorders. Whole genome sequence analysis of DNA from the proband identified homozygous missense variants in AP3B1 and TRAPPC9 that encode proteins involved in sorting and transport of proteins through the Golgi apparatus to lysosomes. Screening of unaffected PBDGs for these variants iden-tified dogs that were homozygous for either variant, but no other dogs that were homozy-gous for both. Conclusion: These findings raise the possibility that the disease involves the combined influence of the two variants, and that the proteins encoded by these genes in-teract within the Golgi apparatus to mediate protein sorting and transport to lysosomes. An alteration in this interaction could underlie the NCL-like lysosomal storage disorder observed in the proband.
- 27 October 2025
- Published by MDPI AG in Preprints.org
Open AccessNeuronal Ceroid Lipofuscinosis-Like Disorder in a Petit Bleu de Gascogne Dog with Sequence Variants in AP3B1 and TRAPPC9
Background/Objectives: A Petit Bleu de Gascogne (PBDG) dog presented with a progressive neurological disorder characterized by hind limb weakness, anxiety and hal-lucinatory episodes, lip smacking, progressive vision loss, muscle atrophy, and ataxia. Magnetic resonance imaging revealed diffuse brain atrophy. The dog was euthanized at approximately 23 months of age due to the progression of neurological signs. A study was undertaken to identify the molecular genetic basis of the disorder in this dog. Methods: Microscopic analyses were performed to characterize the disease pathology and whole genome sequencing was performed to identify the molecular genetic basis of the disorder. Results: The proband exhibited pronounced accumulations of autofluorescent intracellu-lar inclusions in the brain, retina, and heart with ultrastructural appearances similar to those of lysosomal storage bodies that accumulate in the neuronal ceroid lipofuscinosis (NCLs), a group of progressive neurodegenerative disorders. Whole genome sequence analysis of DNA from the proband identified homozygous missense variants in AP3B1 and TRAPPC9 that encode proteins involved in sorting and transport of proteins through the Golgi apparatus to lysosomes. Screening of unaffected PBDGs for these variants iden-tified dogs that were homozygous for either variant, but no other dogs that were homozy-gous for both. Conclusion: These findings raise the possibility that the disease involves the combined influence of the two variants, and that the proteins encoded by these genes in-teract within the Golgi apparatus to mediate protein sorting and transport to lysosomes. An alteration in this interaction could underlie the NCL-like lysosomal storage disorder observed in the proband.
- Open Access
A missense variant in PAOX in American Staffordshire Terriers with juvenile-onset polyneuropathy
Hereditary polyneuropathies in dogs mirror many features of human Charcot-Marie-Tooth (CMT) disease and offer valuable spontaneous models for discovery of genes’ variants involved in this disorder. A juvenile-onset polyneuropathy (JOP) in American Staffordshire Terriers (ASTs) resembles CMT, with motor and sensory deficits, often accompanied by laryngeal paralysis. To identify the underlying genetic cause, we conducted a genome-wide association study (GWAS) with 24 affected and 53 control ASTs that identified a significant locus at the distal end of chromosome 28. Homozygosity mapping analysis further defined a critical interval spanning 11 protein-coding genes and whole-genome sequencing revealed a missense variant in the PAOX gene encoding polyamine oxidase (NC_049249.1:g.41474541G>A), leading to a glycine-to-arginine substitution at a highly conserved residue, XP_038435135.1:p.(Gly382Arg). Genotypes at this variant were homozygous alternate in 96% of the affected dogs (n=53) and either homozygous reference or heterozygous in 336 unaffected ASTs; the mutant allele was not detected in any of 2519 genomes of other dog breeds. In silico predictions consistently supported its pathogenicity, and structural modeling suggested altered substrate binding. Although PAOX expression was preserved, proteomic profiling in affected nerve tissue revealed reduced levels of myelin-associated proteins, as well as dysregulation of mitochondrial and proteasomal pathways. Our findings establish this PAOX missense variant as the likely cause of JOP in ASTs and highlight the breed as a valuable large-animal model for studying inherited peripheral neuropathies. These results expand the spectrum of genes implicated in polyneuropathies and provide a basis for genetic testing and informed breeding strategies in ASTs. Author summary: We studied a hereditary peripheral nerve disorder in American Staffordshire Terriers characterized by exercise intolerance, coordination problems, general weakness and difficulty breathing due to laryngeal paralysis. These signs closely resemble a group of inherited diseases in people known as Charcot-Marie-Tooth disease. To understand the genetic basis of this condition in dogs, we analyzed the genomes of affected and healthy individuals. Our research led us to a single gene, PAOX , which carries a missense variant likely affecting the function of polyamine oxidase and ultimately disrupting how the nerve cells function and survive. Most affected dogs had two copies of the mutant allele, while it was absent or in only one copy in healthy dogs. Additional analyses suggested that the variant may interfere with the nerves’ ability to maintain their structure and function properly. The mutant allele does not appear to reduce the overall level of PAOX protein, but it may affect how the protein works. Our findings provide a new genetic test that can help breeders avoid producing affected puppies. They also highlight this condition in dogs as a valuable model for understanding similar diseases in humans.
Open AccessA missense variant in PAOX in American Staffordshire Terriers with juvenile-onset polyneuropathy
Hereditary polyneuropathies in dogs mirror many features of human Charcot-Marie-Tooth (CMT) disease and offer valuable spontaneous models for discovery of genes’ variants involved in this disorder. A juvenile-onset polyneuropathy (JOP) in American Staffordshire Terriers (ASTs) resembles CMT, with motor and sensory deficits, often accompanied by laryngeal paralysis. To identify the underlying genetic cause, we conducted a genome-wide association study (GWAS) with 24 affected and 53 control ASTs that identified a significant locus at the distal end of chromosome 28. Homozygosity mapping analysis further defined a critical interval spanning 11 protein-coding genes and whole-genome sequencing revealed a missense variant in the PAOX gene encoding polyamine oxidase (NC_049249.1:g.41474541G>A), leading to a glycine-to-arginine substitution at a highly conserved residue, XP_038435135.1:p.(Gly382Arg). Genotypes at this variant were homozygous alternate in 96% of the affected dogs (n=53) and either homozygous reference or heterozygous in 336 unaffected ASTs; the mutant allele was not detected in any of 2519 genomes of other dog breeds. In silico predictions consistently supported its pathogenicity, and structural modeling suggested altered substrate binding. Although PAOX expression was preserved, proteomic profiling in affected nerve tissue revealed reduced levels of myelin-associated proteins, as well as dysregulation of mitochondrial and proteasomal pathways. Our findings establish this PAOX missense variant as the likely cause of JOP in ASTs and highlight the breed as a valuable large-animal model for studying inherited peripheral neuropathies. These results expand the spectrum of genes implicated in polyneuropathies and provide a basis for genetic testing and informed breeding strategies in ASTs. Author summary: We studied a hereditary peripheral nerve disorder in American Staffordshire Terriers characterized by exercise intolerance, coordination problems, general weakness and difficulty breathing due to laryngeal paralysis. These signs closely resemble a group of inherited diseases in people known as Charcot-Marie-Tooth disease. To understand the genetic basis of this condition in dogs, we analyzed the genomes of affected and healthy individuals. Our research led us to a single gene, PAOX , which carries a missense variant likely affecting the function of polyamine oxidase and ultimately disrupting how the nerve cells function and survive. Most affected dogs had two copies of the mutant allele, while it was absent or in only one copy in healthy dogs. Additional analyses suggested that the variant may interfere with the nerves’ ability to maintain their structure and function properly. The mutant allele does not appear to reduce the overall level of PAOX protein, but it may affect how the protein works. Our findings provide a new genetic test that can help breeders avoid producing affected puppies. They also highlight this condition in dogs as a valuable model for understanding similar diseases in humans.
- Open Access
- 11 August 2025
- Published by MDPI AG in Preprints.org
Retinal Function Deficits in American Staffordshire Terriers with a Late-Onset Neurodegenerative Disease Associated with an ARSG Variant
American Staffordshire Terriers (AST) with a c.296G>A variant in ARSG develop progres-sive ataxia, cerebellar atrophy, and neuronal accumulation of autofluorescent storage ma-terial. Human subjects with ARSG variants exhibit hearing loss and rod-cone dystrophy without apparent neurological involvement and arsg knock-out mice exhibit progressive ataxia, lysosomal storage and photoreceptor loss. A study was undertaken to determine whether ASTs homozygous for the c.296G>A variant exhibit retinal dysfunction con-sistent with human subjects and mice with ARSG variants. Owners of 8 of 11 affected ASTs reported observing late-onset visual impairment in their dogs. Affected dogs that were exhibiting signs of ataxia had attenuated electroretinogram (ERG) amplitudes indic-ative of rod and cone photoreceptor dysfunction, while ERG responses were not attenuat-ed in a younger dog that had not yet shown signs of ataxia or visual impairment. Auto-fluorescent inclusions were observed in the retinal pigment epithelium and retinal gan-glion cell layer of two affected dogs that were euthanized due to neurological disease pro-gression. These results indicate that while the disease phenotype varies between humans, mice and dogs with ARSG variants, progressive photoreceptor dysfunction is a consistent feature in all 3 species.
- 11 August 2025
- Published by MDPI AG in Preprints.org
Open AccessRetinal Function Deficits in American Staffordshire Terriers with a Late-Onset Neurodegenerative Disease Associated with an ARSG Variant
American Staffordshire Terriers (AST) with a c.296G>A variant in ARSG develop progres-sive ataxia, cerebellar atrophy, and neuronal accumulation of autofluorescent storage ma-terial. Human subjects with ARSG variants exhibit hearing loss and rod-cone dystrophy without apparent neurological involvement and arsg knock-out mice exhibit progressive ataxia, lysosomal storage and photoreceptor loss. A study was undertaken to determine whether ASTs homozygous for the c.296G>A variant exhibit retinal dysfunction con-sistent with human subjects and mice with ARSG variants. Owners of 8 of 11 affected ASTs reported observing late-onset visual impairment in their dogs. Affected dogs that were exhibiting signs of ataxia had attenuated electroretinogram (ERG) amplitudes indic-ative of rod and cone photoreceptor dysfunction, while ERG responses were not attenuat-ed in a younger dog that had not yet shown signs of ataxia or visual impairment. Auto-fluorescent inclusions were observed in the retinal pigment epithelium and retinal gan-glion cell layer of two affected dogs that were euthanized due to neurological disease pro-gression. These results indicate that while the disease phenotype varies between humans, mice and dogs with ARSG variants, progressive photoreceptor dysfunction is a consistent feature in all 3 species.
- Top Cited Papers
- 1 March 2025
- Published by Human Kinetics in International Journal of Sports Physiology and Performance
- Vol. 20 (3) , 481-484
Training-Load Management Ambiguities and Weak Logic: Creating Potential Consequences in Sport Training and Performance
Background: The optimization of athlete training load is not a new concept; however in recent years, the concept of “load management” is one of the most widely studied and divisive topics in sports science and medicine. Purpose: Discuss the challenges faced by sports when utilizing training load monitoring and management, with a specific focus on the use of data to inform load management guidelines and policies/mandates, their consequences, and how we move this field forward. Challenges: While guidelines can theoretically help protect athletes, overzealous and overcautious guidelines may restrict an athlete’s preparedness, negatively influence performance, and increase injury risk. Poor methods, wrong interpretation of study findings, and faulty logic do not allow for systematic scientific evaluations to inform guidelines. Practical Solutions: Guidelines and mandates should be developed through a systematic research process with stronger research designs and clear research questions. Collaborating with statistical and epidemiological experts is essential. Implementing open science principles and sharing all sports training load data increase transparency and allow for more rapid and valid advancements in knowledge. Practitioners should incorporate multiple data streams and consider individual athlete responses, rather than applying broad guidelines based on average data. Conclusion: Many current training load guidelines and mandates in sports come from good intentions; however, they are arbitrary without sound knowledge of the underlying scientific principles or methods. Common sense guidelines are helpful when there is sparse literature, but they should be careful to avoid arbitrarily choosing findings from weak research. Without precise scientific inquiries, implementing training load interventions or guidelines can have negative implications.
- 1 March 2025
- Published by Human Kinetics in International Journal of Sports Physiology and Performance
- Vol. 20 (3) , 481-484
Top Cited PapersTraining-Load Management Ambiguities and Weak Logic: Creating Potential Consequences in Sport Training and Performance
Background: The optimization of athlete training load is not a new concept; however in recent years, the concept of “load management” is one of the most widely studied and divisive topics in sports science and medicine. Purpose: Discuss the challenges faced by sports when utilizing training load monitoring and management, with a specific focus on the use of data to inform load management guidelines and policies/mandates, their consequences, and how we move this field forward. Challenges: While guidelines can theoretically help protect athletes, overzealous and overcautious guidelines may restrict an athlete’s preparedness, negatively influence performance, and increase injury risk. Poor methods, wrong interpretation of study findings, and faulty logic do not allow for systematic scientific evaluations to inform guidelines. Practical Solutions: Guidelines and mandates should be developed through a systematic research process with stronger research designs and clear research questions. Collaborating with statistical and epidemiological experts is essential. Implementing open science principles and sharing all sports training load data increase transparency and allow for more rapid and valid advancements in knowledge. Practitioners should incorporate multiple data streams and consider individual athlete responses, rather than applying broad guidelines based on average data. Conclusion: Many current training load guidelines and mandates in sports come from good intentions; however, they are arbitrary without sound knowledge of the underlying scientific principles or methods. Common sense guidelines are helpful when there is sparse literature, but they should be careful to avoid arbitrarily choosing findings from weak research. Without precise scientific inquiries, implementing training load interventions or guidelines can have negative implications.
- Open Access
An RB1CC1 Missense Variant in Nova Scotia Duck Tolling Retrievers with Degenerative Encephalopathy
Background/Objectives: A slowly progressive hereditary neurological disorder classified as degenerative encephalopathy (DE) occurs in Nova Scotia Duck Tolling Retrievers. The disease is characterized by frequent episodes of pronounced involuntary movements during sleep, cognitive impairment, anxiety, heightened sensitivity to sensory stimuli, and compulsive behaviors. The clinical signs are accompanied by the degeneration of several brain regions. A study was undertaken to identify the molecular genetic basis of this disorder. Methods: Whole genome sequences (WGSs) from the DNA of affected and unaffected Nova Scotia Duck Tolling Retrievers were aligned to the Dog10K_Boxer_Tasha reference genome assembly and to the WGSs of 334 additional control dogs generated by this laboratory. Results: A missense C>T variant was identified in RB1CC1 exon 22 chromosome 29:4891014 that was uniquely homozygous in the affected dog. This variant predicts a p.G1503R change in the amino acid sequence of RB1CC1. Genotyping of 2950 Nova Scotia Duck Tolling Retrievers at the variant locus found complete concordance between the disease phenotype and RB1CC1 genotype. Conclusions: RBCC1 is an essential component of a protein complex that mediates the initiation of autophagosome formation. Therefore, it appears likely that the disease results, at least in part, from impaired autophagy. Consistent with this possibility, brain neurons of an affected dog were found to contain abnormal lysosomal storage body-like inclusions. This disorder could serve as a valuable model to elucidate the mechanisms underlying human diseases associated with impaired autophagy. Identification of the disease-causing DNA sequence variant will enable owners of Nova Scotia Duck Tolling Retrievers to screen their dogs for the RB1CC1 risk variant.
Open AccessAn RB1CC1 Missense Variant in Nova Scotia Duck Tolling Retrievers with Degenerative Encephalopathy
Background/Objectives: A slowly progressive hereditary neurological disorder classified as degenerative encephalopathy (DE) occurs in Nova Scotia Duck Tolling Retrievers. The disease is characterized by frequent episodes of pronounced involuntary movements during sleep, cognitive impairment, anxiety, heightened sensitivity to sensory stimuli, and compulsive behaviors. The clinical signs are accompanied by the degeneration of several brain regions. A study was undertaken to identify the molecular genetic basis of this disorder. Methods: Whole genome sequences (WGSs) from the DNA of affected and unaffected Nova Scotia Duck Tolling Retrievers were aligned to the Dog10K_Boxer_Tasha reference genome assembly and to the WGSs of 334 additional control dogs generated by this laboratory. Results: A missense C>T variant was identified in RB1CC1 exon 22 chromosome 29:4891014 that was uniquely homozygous in the affected dog. This variant predicts a p.G1503R change in the amino acid sequence of RB1CC1. Genotyping of 2950 Nova Scotia Duck Tolling Retrievers at the variant locus found complete concordance between the disease phenotype and RB1CC1 genotype. Conclusions: RBCC1 is an essential component of a protein complex that mediates the initiation of autophagosome formation. Therefore, it appears likely that the disease results, at least in part, from impaired autophagy. Consistent with this possibility, brain neurons of an affected dog were found to contain abnormal lysosomal storage body-like inclusions. This disorder could serve as a valuable model to elucidate the mechanisms underlying human diseases associated with impaired autophagy. Identification of the disease-causing DNA sequence variant will enable owners of Nova Scotia Duck Tolling Retrievers to screen their dogs for the RB1CC1 risk variant.
- Open Access
- 5 February 2025
- Published by MDPI AG in Preprints.org
An RB1CC1 Missense Variant in Nova Scotia Duck Tolling Retrievers with Degenerative Encephalopathy
A slowly progressive neurological disorder classified as degenerative encephalopathy (DE) occurs in Nova Scotia Duck Tolling Retrievers. The disease is characterized by frequent episodes of pronounced involuntary movements during sleep, cognitive impairment, anxiety, heightened sensitivity to sensory stimuli, and compulsive behaviors. The onset of these signs occurs between 2 months and 5 years of age. Late signs include aggressive behavior, gait abnormalities, and urinary and fecal incontinence. The clinical signs are accompanied by degeneration of the cerebellum, caudate nucleus, and substantia nigra. Next-generation sequencing was used to generate whole-genome sequences from the DNA of affected and unaffected Nova Scotia Duck Tolling Retrievers. The resulting sequences were aligned to the Dog10K_Boxer_Tasha reference genome assembly and the whole genome sequences (WGS) of 334 additonal control canine whole genome sequences generated by the University of Missouri Canine Genetics Laboratory. Analysis of the WGS data identified a missense variant in RB1CC1 exon 22 chromosome 29:4891014, C>T that was uniquely homozygous in the affected dog. This variant predicts a p.G1503R change in the amino acid sequence of RB1CC1. Genotyping of 2,950 Nova Scotia Duck Tolling Retrievers at the variant locus found complete concordance between the disease phenotype and RB1CC1 genotype. RBCC1 is an essential component of a protein complex that mediates the initiation of autophagosome formation. Therefore, it appears likely that the disease results at least in part from impaired autophagy. Consistent with possibility, caudate nucleus neurons of an affected dog were found to contain abnormal lysosomal storage body-like inclusions bodies with heterogenous contents. This disorder could serve as a valuable model to elucidate the mechanisms underlying human diseases associated with impaired autophagy. Identification of the disease-causing DNA sequence variant will enable owners of Nova Scotia Duck Tolling Retrievers to screen their dogs for the RB1CC1 risk variant.
- 5 February 2025
- Published by MDPI AG in Preprints.org
Open AccessAn RB1CC1 Missense Variant in Nova Scotia Duck Tolling Retrievers with Degenerative Encephalopathy
A slowly progressive neurological disorder classified as degenerative encephalopathy (DE) occurs in Nova Scotia Duck Tolling Retrievers. The disease is characterized by frequent episodes of pronounced involuntary movements during sleep, cognitive impairment, anxiety, heightened sensitivity to sensory stimuli, and compulsive behaviors. The onset of these signs occurs between 2 months and 5 years of age. Late signs include aggressive behavior, gait abnormalities, and urinary and fecal incontinence. The clinical signs are accompanied by degeneration of the cerebellum, caudate nucleus, and substantia nigra. Next-generation sequencing was used to generate whole-genome sequences from the DNA of affected and unaffected Nova Scotia Duck Tolling Retrievers. The resulting sequences were aligned to the Dog10K_Boxer_Tasha reference genome assembly and the whole genome sequences (WGS) of 334 additonal control canine whole genome sequences generated by the University of Missouri Canine Genetics Laboratory. Analysis of the WGS data identified a missense variant in RB1CC1 exon 22 chromosome 29:4891014, C>T that was uniquely homozygous in the affected dog. This variant predicts a p.G1503R change in the amino acid sequence of RB1CC1. Genotyping of 2,950 Nova Scotia Duck Tolling Retrievers at the variant locus found complete concordance between the disease phenotype and RB1CC1 genotype. RBCC1 is an essential component of a protein complex that mediates the initiation of autophagosome formation. Therefore, it appears likely that the disease results at least in part from impaired autophagy. Consistent with possibility, caudate nucleus neurons of an affected dog were found to contain abnormal lysosomal storage body-like inclusions bodies with heterogenous contents. This disorder could serve as a valuable model to elucidate the mechanisms underlying human diseases associated with impaired autophagy. Identification of the disease-causing DNA sequence variant will enable owners of Nova Scotia Duck Tolling Retrievers to screen their dogs for the RB1CC1 risk variant.
- Open Access
Canine Multiple System Degeneration Associated with Sequence Variants in SERAC1
Canine multiple system degeneration (CMSD) is an early onset, progressive movement disorder affecting Kerry Blue Terriers and Chinese Crested dogs. The associated pathologic lesions include degeneration of the cerebellum, caudate nucleus, and substantia nigra. CMSD is inherited as an autosomal recessive trait in both dog breeds. Previous linkage mapping localized the CMSD locus to a 15 MB region on canine chromosome 1 (CFA1). Next-generation sequencing was used to generate whole-genome sequences from the DNA of an affected dog from each breed. The resulting sequence reads were aligned to the NCBI canine reference genome (build 3.1). Among the homozygous sequence variants within the CFA1 target region, a nonsense variant in exon 15 of SERAC1 was identified in the affected Kerry Blue Terrier, while in the Chinese Crested dog, a 4 bp deletion in the SERAC1 exon 4 acceptor splice site was found. RT-PCR showed that this deletion resulted in exon 4 skipping. Genotyping of large cohorts of Kerry Blue Terriers and Chinese Crested dogs for the respective breed-specific SERAC1 variants showed complete concordance between genotype and disease phenotype. Genotype–phenotype concordance was also observed in offspring generated by cross breeding between SERAC1-heterozygous Kerry Blue Terrier and Chinese Crested dogs, with only the compound heterozygotes exhibiting the disease phenotype, further confirming the recessive inheritance of CMSD. Variants in human SERAC1 are associated with disorders with a range of ages of disease onset and patterns of clinical signs, but that are all characterized by movement abnormalities similar to those of the dogs with CMSD. Canine CMSD could serve as a valuable model to elucidate the mechanisms underlying SERAC1-deficiency disorders and to evaluate potential therapeutic interventions.
Open AccessCanine Multiple System Degeneration Associated with Sequence Variants in SERAC1
Canine multiple system degeneration (CMSD) is an early onset, progressive movement disorder affecting Kerry Blue Terriers and Chinese Crested dogs. The associated pathologic lesions include degeneration of the cerebellum, caudate nucleus, and substantia nigra. CMSD is inherited as an autosomal recessive trait in both dog breeds. Previous linkage mapping localized the CMSD locus to a 15 MB region on canine chromosome 1 (CFA1). Next-generation sequencing was used to generate whole-genome sequences from the DNA of an affected dog from each breed. The resulting sequence reads were aligned to the NCBI canine reference genome (build 3.1). Among the homozygous sequence variants within the CFA1 target region, a nonsense variant in exon 15 of SERAC1 was identified in the affected Kerry Blue Terrier, while in the Chinese Crested dog, a 4 bp deletion in the SERAC1 exon 4 acceptor splice site was found. RT-PCR showed that this deletion resulted in exon 4 skipping. Genotyping of large cohorts of Kerry Blue Terriers and Chinese Crested dogs for the respective breed-specific SERAC1 variants showed complete concordance between genotype and disease phenotype. Genotype–phenotype concordance was also observed in offspring generated by cross breeding between SERAC1-heterozygous Kerry Blue Terrier and Chinese Crested dogs, with only the compound heterozygotes exhibiting the disease phenotype, further confirming the recessive inheritance of CMSD. Variants in human SERAC1 are associated with disorders with a range of ages of disease onset and patterns of clinical signs, but that are all characterized by movement abnormalities similar to those of the dogs with CMSD. Canine CMSD could serve as a valuable model to elucidate the mechanisms underlying SERAC1-deficiency disorders and to evaluate potential therapeutic interventions.